カテゴリ： MarketLine, フランス, 企業調査

Diana S.A.S.：戦略・SWOT・企業財務分析

◆英語タイトル：Diana S.A.S. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015716
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：27
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Diana S.A.S. – Strategy, SWOT and Corporate Finance Report
Summary

Diana S.A.S. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DIANA S.A.S. (Diana) is a biotechnology company based in France. The company primarily develops and provides organoleptic solutions based on natural ingredients. It produces palatability enhancer in pet food and natural functional solutions for food. The company is also involved in development of plant cell culture and aquaculture. Diana operates through its subsidiaries and affiliates including Diana Naturals, Cap Diana, SPF, Aquativ and DianaPlantSciences. It operates industrial sites and commercial offices across the globe. The company operates as a subsidiary of Symrise AG. Diana is headquartered in Vannes, France.

Scope

- Detailed information on Diana S.A.S. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Diana S.A.S. in the form of a SWOT analysis
- An in-depth view of the business model of Diana S.A.S. including a breakdown and examination of key business segments
- Intelligence on Diana S.A.S.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Diana S.A.S., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Diana S.A.S. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Diana S.A.S. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Diana S.A.S.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Diana S.A.S.: Company Overview
Diana S.A.S.: Overview and Key Facts
Diana S.A.S.: Overview
Diana S.A.S.: Key Facts
Diana S.A.S.: Key Employees
Diana S.A.S.: Major Products and Services
Diana S.A.S.: Company History
Diana S.A.S.: Locations and Subsidiaries
Diana S.A.S.: Key Competitors
Diana S.A.S.: Company Analysis
Diana S.A.S.: Business Description
Diana S.A.S.: SWOT Analysis
Diana S.A.S.: SWOT Overview
Diana S.A.S.: Strengths
Diana S.A.S.: Weaknesses
Diana S.A.S.: Opportunities
Diana S.A.S.: Threats
Diana S.A.S.: Corporate Financial Deals Activity
Diana S.A.S.: Financial Deals Overview
Diana S.A.S.: Targets and Partners
Diana S.A.S.: Top Deals 2013 – 2017YTD*
Diana S.A.S.: Mergers and Acquisitions
Diana S.A.S.: Recent Developments
Diana S.A.S.: News and Events Summary
Diana S.A.S.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Diana S.A.S.: Key Facts
Table 2: Diana S.A.S.: Key Employees
Table 3: Diana S.A.S.: Locations and Subsidiaries
Table 4: Diana S.A.S.: Key Competitors
Table 5: Diana S.A.S.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Diana S.A.S.: M&A Activity by Geography (TTM*)
Table 7: Diana S.A.S.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Diana S.A.S.: Targets and Partners
Table 9: Diana S.A.S.: Top Deals 2013 - 2017YTD*
Table 10: Diana S.A.S.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: Diana S.A.S.: M&A Activity by Geography (2013 - YTD*2017)
Table 12: Diana S.A.S.: News and Events Summary
Table 13: Diana S.A.S.: Regulatory and Legal Events

★海外企業調査レポート[Diana S.A.S.：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Greensmith Energy Management Systems LLC-エネルギー分野：企業M&A・提携分析
    Summary Greensmith Energy Management Systems, LLC (Greensmith) is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, C&I or Micro-grid deployments. It offer …
  • Humana Inc (HUM)：企業の財務・戦略的SWOT分析
    Humana Inc (HUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BE Semiconductor Industries N.V. (BESI)：企業の財務・戦略的SWOT分析
    BE Semiconductor Industries N.V. (BESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Samsung Heavy Industries Co., Ltd.：企業の戦略・SWOT・財務分析
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Intellia Therapeutics Inc (NTLA)：企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Synthetic Biologics Inc (SYN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • SNC-Lavalin Group Inc.：企業のM&A・事業提携・投資動向
    SNC-Lavalin Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SNC-Lavalin Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Punjab & Sind Bank：企業の戦略・SWOT・財務情報
    Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Expro Holdings UK 3 Ltd：企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Max Delbruck Center for Molecular Medicine：製薬・医療：M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • Gulfport Energy Corp (GPOR)：企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • GS Yuasa Corp (6674)：企業の財務・戦略的SWOT分析
    GS Yuasa Corp (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Intas Pharmaceuticals Ltd：企業の戦略的SWOT分析
    Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NiSource Inc (NI)：石油・ガス：M&Aディール及び事業提携情報
    Summary NiSource Inc (NiSource) is a regulated energy utility. The company distributes natural gas; and generates, transmits and distributes electricity. It produces electricity from coal, gas and hydro sources. NiSource operates electricity transmission systems and natural gas transmission pipeline …
  • Tyser & Co Limited：企業の戦略的SWOT分析
    Tyser & Co Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Apexigen Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of cancer. The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell responses. It also …
  • CEL-SCI Corp (CVM)：製薬・医療：M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Severn Trent Plc：企業の戦略・SWOT・財務情報
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China North Industries Corporation：企業の戦略・SWOT・財務情報
    China North Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary China North Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • BillerudKorsnas AB：企業の戦略・SWOT・財務情報
    BillerudKorsnas AB - Strategy, SWOT and Corporate Finance Report Summary BillerudKorsnas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆